ICD-10-CM Billable Code

N02.3

Recurrent and persistent hematuria with diffuse mesangial proliferative glomerulonephritis

Clinical Classification Guidelines

Medical Intelligence & Overview

Recurrent and persistent hematuria, characterized by blood in the urine, combined with diffuse mesangial proliferative glomerulonephritis, is a specific kidney condition. This disorder involves inflammation and proliferation within the mesangial cells of the glomeruli, the tiny filtering units in the kidneys. The persistent presence of blood in the urine indicates ongoing kidney damage, which may require medical attention to prevent further complications. Understanding this condition can help in recognizing its symptoms, potential causes, and available treatment options.

Causes & Symptoms

Clinical Causes: Autoimmune diseases such as lupus erythematosus Infections that affect the kidneys, including post-infectious glomerulonephritis Certain genetic conditions affecting kidney function Vasculitis, which involves inflammation of blood vessels Other immune system disorders that lead to kidney inflammation

Key Symptoms: Persistent or recurrent blood in the urine (hematuria) Foamy urine due to protein loss Swelling in the legs, ankles, or around the eyes High blood pressure Fatigue and general malaise Possible flank pain or discomfort

Diagnostic & Treatment

Diagnosis Path: Diagnosing this condition involves a combination of medical history, physical examinations, and specialized tests. Key diagnostic procedures include: - Urinalysis: detects blood and protein in the urine - Blood tests: assess kidney function and look for signs of immune activity - Imaging studies: such as ultrasound to visualize kidney structure - Kidney biopsy: a small sample of kidney tissue examined under a microscope to confirm mesangial proliferation and inflammation These assessments help determine the extent of kidney damage and the specific type of glomerulonephritis present.

Treatment Protocols: Management of this condition aims to control inflammation, reduce symptoms, and prevent further kidney damage. Typical approaches include: - Medications such as corticosteroids to reduce inflammation - Immunosuppressive drugs to modulate immune responses - Blood pressure management, often with ACE inhibitors or ARBs - Diuretics to manage swelling - Dietary modifications to reduce salt and protein intake - Regular monitoring of kidney function and urine analysis In some cases, more advanced interventions might be necessary, including dialysis or kidney transplantation if kidney failure develops. Early detection and continual care are essential for improving outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N02.3 a billable ICD-10 code?
Yes, N02.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N02.3?
Clinical documentation must specify the nature of Recurrent and persistent hematuria with diffuse mesangial proliferative glomerulonephritis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

proliferative glomerulonephritis recurrent persistent hematuria diffuse mesangial